Institutions in the Managed Care Environment

  • Volker Eric Amelung
Part of the Springer Texts in Business and Economics book series (STBE)


Since “Wall Street discovered healthcare” a long time ago, not only is the age of peaceful coexistence between service providers and payers is over, but an entirely new consulting market has developed. However, the types of products differ widely. The products can be broken down into three categories. First, there are consultation products that are meant to increase the efficiency of the provision of services. Among these, the following are particularly relevant: Management service organisations (MSO), physician practice management companies (PPMC) and pharmacy benefit management organisations (PBM). The second type of consultation products concentrates on the individual managed care instruments. Therefore, consulting services have partially specialised in conducting utilisation reviews or developing guidelines. These forms of consultation will not be explained in more detail here because individual instruments will be extensively discussed.


  1. Burns, L. R., & Robinson, J. C. (1998). Physician practice management companies: Implications for hospital-based integrated delivery systems. Frontiers of Health Service Management, 14(2), 3–35.CrossRefGoogle Scholar
  2. California Healthcare Foundation. (2016). Health care costs 101: ACA spurs modest growth. Accessed July 19, 2016, from
  3. Cap Gemini, Ernst & Young. (2003). Versandhandel mit Arzneimitteln in den USA – Ein Konzept für Deutschland? Internationale Studie, ausführliche Fassung. Accessed February 19, 2013, from
  4. Cebul, R. D., Rebitzer, J. B., Taylor, L. J., et al. (2008). Organizational fragmentation and care quality in the U.S. health care system (NBER Working Paper Series). Cambridge, MA.Google Scholar
  5. Conrad, D. A., Koos, S., Harney, A., et al. (1999). Physician practice management organizations: Their prospects and performance. Medical Care Research and Review, 56(3), 307–339.CrossRefGoogle Scholar
  6. Grabowski, H., & Mullins, C. D. (1997). Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions. Social Science & Medicine, 45(4), 545–554.CrossRefGoogle Scholar
  7. Green, K. (2008). Regulation of pharmacy benefit managers: An economic analysis of regulation and litigation as agents of health care change (Working Paper). Accessed March 13, 2018, from context/kevin_green/article/1000/type/native/viewcontent/
  8. Greenwald, H. P. (2010). Health care in the United States: Organization, management, and policy. San Francisco: Jossey-Bass.Google Scholar
  9. Guest, B. C., & Collins, M. E. (2010). Is it time to resurrect physician practice management organizations? Health leaders media. Accessed March 13, 2018, from 247842/Is-it-Time-to-Resurrect-Physician-Practice-Management-Organizations
  10. Haas-Wilson, D. (2003). Managed care and monopoly power: The antitrust challenge. Cambridge, MA: Harvard University Press.Google Scholar
  11. Hoechst Marion Roussel. (1999). Medical group practice digest (Managed care digest series). Kansas City: Hoechst Marion Roussel.Google Scholar
  12. Hoffman, J. R. (1997). Management service organizations. In K. Miller & E. Miller (Eds.), Making sense of managed care (pp. 91–99). San Francisco: American College of Physician Executives.Google Scholar
  13. KFF [Kaiser Family Foundation]. (2005). The effect of formularies and other cost management tools on access to medications: An analysis of the MMA and the final rule. Menlo Park: Kaiser Family Foundation.Google Scholar
  14. Kongstvedt, P. R. (2009). Managed care: What it is and how it works (3rd ed.). Sudbury: Jones & Bartlett.Google Scholar
  15. Kongstvedt, P. R. (2013). Essentials of managed health care (6th ed.). Burlington, VT: Jones & Bartlett.Google Scholar
  16. Kopenski, F. (2008). Prescription drug benefit design: The building blocks and their impact on costs. Benefits Quarterly, Fourth Quarter, 24(4), 7–11.Google Scholar
  17. Mello, T. J., & Newsad, N. A. (2014). White Paper: Management Services. Accessed July 19, 2016, from
  18. Nauert, R. C., & Weissman, D. C. (1999). MSO development: Progress versus pitfalls. Journal of Health Care Finance, 25(3), 37–43.Google Scholar
  19. Navarro, R. P. (2009). Managed care pharmacy practice (2nd ed.). Sudbury: Jones & Bartlett.Google Scholar
  20. PCMA [Pharmaceutical Care Management Association]. (2010). Pharmacy benefit manager (PBM) 101. Accessed February 26, 2013, from
  21. PWC [Price Waterhouse Coopers]. (2007). Pharmacy benefit management savings in Medicare and the commercial marketplace & the cost of proposed PBM legislation, 2008–2017. Accessed March 13, 2018, from http://www. pdf
  22. Robinson, J. C. (1998). Financial capital and intellectual capital in physician practice management. Health Affairs, 17, 53–74.CrossRefGoogle Scholar
  23. Sanofi. (2015). Managed care digest series–HMO-PPO digest 2015. Bridgewater: Sanofi.Google Scholar
  24. Santerre, R. E., & Neun, S. P. (2010). Health economics: Theory, insights, and industry studies (5th ed.). Mason: South-West Cengage Learning.Google Scholar
  25. Smith, M. I., Wertheimer, A. I., & Fincham, J. E. (2005). Pharmacy and the U.S. health care system (3rd ed.). Binghamton: Haworth Press.CrossRefGoogle Scholar
  26. Todd, M. K. (2011). The physician employment contract handbook: A guide to structuring equitable arrangements (2nd ed.). New York: Productivity Press.Google Scholar
  27. Visante. (2011). Pharmacy benefit managers (PBMs): Generating savings for plan sponsors and consumers. Accessed February 26, 2013, from percent20studypercent202011percent20final.pdf
  28. Zuckerman, H. S., Hilberman, D. W., Andersen, R. M., et al. (1998). Physicians and organizations: Strange bedfellows or a marriage made in heaven? Frontiers of Health Service Management, 14(3), 3–34.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Volker Eric Amelung
    • 1
    • 2
  1. 1.Institute for Epidemiology, Social Medicine and Health Systems ResearchHannover Medical SchoolHannoverGermany
  2. 2.Institute of Health Sciences Research INAV GmbHBerlinGermany

Personalised recommendations